Personnel Moves Archives - Page 6 of 42

BD hires new chief medical officer from 3M Health Care

Dr. Ron Silverman is the next chief medical officer of Becton, Dickinson & Co. [Photo courtesy of BD]Becton, Dickinson & Co. (NYSE: BDX) + today named Dr. Ronald “Ron” Silverman as EVP and chief medical officer.

He replaces BD Chief Medical Officer Dr. William Sigmund, who announced plans to retire from BD earlier this year. The change takes effect Dec. 4, 2023.

Silverman comes from 3M Health Care, where he served as SVP and chief medical officer since 2021. He will lead BD’s medical affairs organization across BD’s business units, regions and central team.

Franklin Lakes, New Jersey-based BD said Silverman “will use medical insights and expertise to advance BD’s pipeline of clinically relevant, innovative solutions that align with evolving patient needs, while also contributing to the safety and compliance of BD’s in-market portfolio of products.”

Silv…

Neptune Medical brings on Intuitive co-founder as its board chair

Neptune Medical, the parent company of Triton Medical Robotics, has appointed a new board chair — and he’s well-known in surgical robotics.

Dr. Fred Moll co-founded surgical robotics pioneer Intuitive in 1995. In recent years, he led robotic surgery developer Auris Health to its $3.4 billion sale to Johnson & Johnson in 2019. He’s presently a managing partner at healthcare technology venture capital firm Sonder Capital — and is board chair at Procept BioRobotics and Moon Surgical. He’s also a board member at Shockwave Medical.

“We are thrilled to welcome Dr. Fred Moll as the chairman of the board at Neptune Medical,” Alex Tilson, the company’s founder and CEO, said in a news release. “His unparalleled experience in the medical technology sector will be invaluable as we continue to grow and advance our mission of transforming healthcare with innovative products.”

Dr. Fred Moll [Image courtesy of Neptune Med…

NeuroOne picks former Cardiovascular Systems VP as new COO

NeuroOne Medical Technologies (Nasdaq:NMTC) announced that it appointed Christopher R. Volker as its chief operating officer (COO).

Volker joins the Eden Prairie, Minnesota-based neurotech company from Abbott. He previously served as VP and GM of international at Cardiovascular Systems (CSI), which Abbott acquired earlier this year.

“Chris’ appointment further strengthens our executive leadership team and deepens our capabilities as we build for future commercial growth and expansion into other clinical applications,” said NeuroOne CEO Dave Rosa. “We are excited to benefit from his broad experience in business development, commercial expansion, finance and health economics, and reimbursement.”

NeuroOne commercially launched its Evo sEEG electrode line in the U.S. earlier this year. The electrodes provide up to 30 days of recording, monitoring and stimulation of electrical signals at the subsurface level of the brain.

The company is als…

Inogen has a new CEO

Kevin Smith [Image courtesy of Smith’s LinkedIn profile]Inogen (Nasdaq: INGN), which specializes in respiratory products for homecare, announced a change in the corner office today.

The company’s board of directors has named Kevin Smith as Inogen’s new president and CEO, effective immediately. Smith succeeds Nabil Shabshab, who started as CEO in 2021.

Smith has over two decades of experience in the medical device sector, including in respiratory care and durable medical equipment. His most recent role was CEO at Sirtex Medical, a manufacturer of interventional treatment solutions. He’s held senior roles at Sensium Healthcare, Teleflex, Hillrom Holdings and Zoll Medical.

“We believe we have tremendous opportunities to scale our business, drive operational efficiencies and accelerate our growth trajectory, and the board believes it is the right time for new leadership to improve performance and support Inogen’s next phase of its journe…

ResMed has a new operating model following recent layoffs

ResMed (NYSE: RMD) + announced that it’s implementing a new operating model to accelerate long-term growth.

San Diego-based ResMed’s operational shift follows a recent restructuring effort that included a 5% workforce reduction. The new operating model introduces dedicated leadership in product, revenue and marketing to the company’s executive team. It includes a series of executive moves within the company’s leadership team.

Justin Leong, previously ResMed’s president for Asia and Latin America, takes over as the new chief product officer. The company selected its president in Germany, Katrin Pucknat, as its chief marketing officer. Mike Fliss, previously VP of North America sales, assumes the post of chief revenue officer.

These moves aim to increase the velocity of product development and sharpen customer and brand focus, according to a news release. The sleep respiratory technol…

3M Health Care Group president is leaving ahead of spinoff

Departing 3M Health Care President Jeff Lavers. [Image from Jeff Lavers on LinkedIn]3M (NYSE: MMM) + announced today that Jeff Lavers, group president of its Health Care Business Group, intends to depart the company.

The departure of Lavers — which goes into effect on Dec. 1 — arrives in conjunction with the company’s planned Health Care spinoff. 3M said last month that it expects to complete that spinoff in early 2024.

The company said it plans for new Health Care CEO Bryan Hanson to continue leading the business as it works toward the spinoff. Hanson announced his departure from the corner office at Zimmer Biomet to take over the company in August. The company also landed former Insulet CFO Wayde McMillan as he takes over the same post.

3M Health Care is one of the largest medtech businesses in the world, with more than $8 billion in annual revenue.

The company also noted the departure of Ashish Khan…

Enable Injections adds finance veteran to its board

New Enable Injections board member Vickie Capps. [Image from NuVasive]Enable Injections announced today that it appointed Vickie Capps to its board of directors as the head of the audit committee.

Capps joins the wearable drug delivery system maker with plenty of experience in finance and executive leadership. She also brings extensive board experience, including currently serving on the board of orthopedic company NuVasive.

Other boards Capps serves on include Amedisys and Janux Therapeutics. She serves as a member of the senior advisory board at Consonance Capital Partners, a healthcare-focused private equity firm. Her record includes serving as CFO of DJO Global from 2002 to 2013 as well.

Capps joins the board of Enable Injections at a good time. The company just picked up FDA approval for its enFuse injector for the delivery of Empaveli.

Get the full story at our sister site, Drug Delivery Business News.

Cordis has a new CEO

Cordis CEO Scott Drake [Photo courtesy of Cordis]About two months after former Spectranetics CEO Scott Drake became executive board chair at Cordis, he’s moved into the corner office at the cardiology and endovascular devices company.

Drake replaces Shar Matin, who has stepped down as CEO, the company announced yesterday.

Hunter Philbrick, Hellman & Friedman partner and company board member, noted in a news release that Drake has been on the board since H&F acquired the company from Cardinal Health in 2021.

“He has a long history building world-class medical device organizations, bringing to market groundbreaking patient-saving innovations and driving commercial excellence — along with the reputation of attracting, retaining, and developing world-class talent. Scott believes in Cordis’ ability to transform the medical industry, and with him as CEO, Cordis will achieve its vision of pioneering breakthrough cardiovascular technologies.”

D…

Cordis has a new CEO

Cordis CEO Scott Drake [Photo courtesy of Cordis]About two months after former Spectranetics CEO Scott Drake became executive board chair at Cordis, he’s moved into the corner office at the cardiology and endovascular devices company.

Drake replaces Shar Matin, who has stepped down as CEO, the company announced yesterday.

Hunter Philbrick, Hellman & Friedman partner and company board member, noted in a news release that Drake has been on the board since H&F acquired the company from Cardinal Health in 2021.

“He has a long history building world-class medical device organizations, bringing to market groundbreaking patient-saving innovations and driving commercial excellence — along with the reputation of attracting, retaining, and developing world-class talent. Scott believes in Cordis’ ability to transform the medical industry, and with him as CEO, Cordis will achieve its vision of pioneering breakthrough cardiovascular technologies.”

D…

Silk Road Medical names a new CEO

Chas McKhann [Image from LinkedIn]Silk Road Medical (Nasdaq:SILK) announced today that it appointed Chas McKhann as its new CEO, effective immediately.

Located in Sunnyvale, California and Plymouth, Minnesota, Silk Road Medical is focused on reducing stroke risk through a carotid artery disease treatment called TransCarotid Artery Revascularization (TCAR). The company announced last month that CEO Erica Rogers intended to retire. She will continue serving as an advisor to the board.

The company’s plan included Rogers formally retiring once Silk Road completed the succession process. The company enlisted executive search firm Spencer Stuart to help find a replacement CEO. It now has a successor to the CEO who held the corner office for 11 years: Chas McKhann.

“Chas is a skilled and experienced leader with a track record of effectively building and scaling medical device businesses into underpenetrated markets. We are excited to welcome him to Silk Road…

The Mullings Group acquires M. J. Moore & Associates and names Michael Moore partner

NEWS RELEASE: The Mullings Group acquires M. J. Moore & Associates and names Michael Moore partner

Delray Beach, Florida (Nov. 1, 2023) – The Mullings Group, a leading talent acquisition firm headquartered in the U.S. specializing in medical & health technology, life sciences, and emerging high-tech industries, announces the acquisition of M. J. Moore & Associates. The founder of M. J. Moore & Associates, Michael Moore, will join the TMG team as a partner and continue building companies and careers within our industries.

TMG has over three decades of building companies and careers and is the industry’s largest and most successful search firm in the MedTech/HealthTech market, with offices in the U.S., Canada, the U.K., and APAC. The search firm is responsible for more than 8,000 successful searches with over 800+ clients ranging from multi-billion-dollar companies to emerging tech startups worldwide.

Mike has spent the past 25 years working…

Intuitive appoints Align Technology exec to its board

New Intuitive board member Sreelakshmi Kolli. [Image from Zimmer Biomet]Intuitive (Nasdaq: ISRG) + announced that it appointed Align Technology executive Sreelakshmi Kolli to its board of directors.

Kolli currently serves as EVP and chief digital officer at Align, the maker of Invisalign clear aligners and other dental tech. Her appointment to Intuitive’s board of directors went into effect on Oct. 27, 2023.

“Sree has deep expertise in applying technology to transform industries, enable business growth and drive strategy,” said Intuitive CEO Gary Guthart. “We look forward to her insights, particularly with respect to digital capabilities and meaningful customer experiences, as we continue to advance what’s possible in minimally invasive care.”

Kolli’s current role at Align holds responsibility for leading software, data, enterprise, cloud and infrastructure engineering. Her focus centers around the desi…